Intractable hypotension is a major cause of death after glyphosate-surfactant herbicide poisoning. However, there is no specific treatment besides conservative care. Herein, we report a patient poisoned by glyphosatesurfactant herbicide experiencing cardiac arrest but was successfully resuscitated and treated with continuous venovenous haemodiafiltration (CVVHDF). The 60-year-old patient was brought to our emergency department after ingesting glyphosate-surfactant herbicide. He developed pulmonary oedema, severe metabolic acidosis (pH 6.960), and hyperkalaemia (serum potassium 8.8 mmol/L). Although he experienced cardiac arrest for about 12 minutes, the use of CVVHDF improved the metabolic acidosis and hyperkalaemia, and finally stabilised his vital signs. He regained an alert mental state after therapeutic hypothermia. CVVHDF, which is a better tolerated renal replacement therapy than haemodialysis in haemodynamically unstable patients, should be considered in glyphosate-surfactant poisoned patients of intractable hypotension with severe metabolic acidosis or hyperkalaemia. (Hong Kong j.emerg.med. 2012;19:214-217) 頑固性低血壓是草甘膦除草劑中毒致命的主因。然而，除了保守性治療外沒有專門的療法。我們於此報 告一例以連續性靜靜脈血液透析濾過（CVVHDF）成功救治草甘膦除草劑中毒後心跳停頓的病人。 該名 6 0 歲病人在攝入草甘膦除草劑後被送到我們的急症室。他出現肺水腫、嚴重的代謝性酸中毒 （pH 6.960） 和高鉀血症（血清鉀濃度 8.8 mmol/L）。儘管他的心跳停頓了 12 分鐘， CVVHDF 的 運用舒緩了代謝性酸中毒和高鉀血症，並最終穩定了生命特徵。他在接受低溫治療後恢復了知覺。草甘 膦除草劑中毒導致頑固性低血壓，並出現代謝性酸中毒和高鉀血症時，應考慮使用在血液動力不穩定病 人身上比血液透析更優勝的 CVVHDF 作為腎臟替代治療。
Introduction
Glyphosate-surfactant herbicide (GlySH) is a common post-emergent nonselec tive herbicide used in agriculture. The American Association of Poison Control Centers has reported GlySH as the most common herbicide with human exposure in the United States. 1 
It is generally considered that GlySH herbicide
The patient was put on mechanical ventilation due to respiratory fatigue and pulmonary oedema. We started supportive care, including hydration and correction of hyperkalaemia using sodium bicarbonate, calcium gluconate, and insulin/dextrose infusion. About two hours after the ingestion, he developed cardiac arrest with pulseless electrical activity. He had return of spontaneous circulation after 12 minutes of cardiopulmonary resuscitation with 3 mg of adrenaline given. After the return of spontaneous circulation, he still had hypotension and persistent metabolic acidosis. Dopamine and noradrenaline were infused for hypotension. Therapeutic hypothermia was induced using an endovascular cooling device and renal replacement therapy was instituted by means of CVVHDF. The hypotension gradually improved; noradrenaline was discontinued four hours after i n i t i a t i o n o f C V V H D F , a n d d o p a mi n e w a s discontinued 10 hours after initiation of CVVHDF ( Figure 1 ). The metabolic acidosis and the other arterial blood gas parameters started to improve to pH 7.351, PaCO 2 4.0 kPa, PaO 2 14.8 kPa and bicarbonate 16.3 mmol/L, and finally reached normal range seven hours after beginning CVVHDF (Figure 1 ). The ECG displayed normal sinus rhythm with more shortened QTc compared with the previous ECG. CVVHDF was maintained for 48 hours. Therapeutic hypothermia was maintained at a target temperature of 33 o C for 24 hours and then normothermia was maintained for 24 hours. The infusion of sedative drugs was discontinued 48 hours after the beginning of CVVHDF, after that the patient became alert. He was weaned from the mechanical ventilator and extubated on the seventh hospital day. The patient was discharged uneventfully on the nineteenth hospital day.
Discussion
Commercially available GlySH usually contains 41% glyphosate as an isopropylamine salt (IPAG) and 15% POEA as the surfactant. An animal study has reported that IPAG, POEA, or both were responsible for GlySH toxicity. 7 Although the mechanism of GlySH toxicity is not completely understood, uncoupling mitochondrial oxidative phosphorylation and reducing is not significantly toxic. However, in Asian studies, the fatality rate has been reported variously from 7.2% to 29.3% in series of intentional ingestion of GlySH. 2, 3 Although the major pathophysiology of death in GlySH intoxicated patients is unclear, several studies have suggested that intractable shock, metabolic acidosis, and pulmonary oedema were poor prognostic factors. [2] [3] [4] Refractor y hypotension after GlySH ingestion is particularly difficult to treat, as there is no antidotal treatment besides supportive care. While there is no definitive treatment for intractable hypotension, two case reports have recommended considering the use of haemodialysis or lipid emulsion. 5, 6 We report a successfully resuscitated patient who experienced cardiac arrest after GlySH ingestion and was treat ed with continuo us venovenous haemodiafiltration (CVVHDF) and therapeutic hypothermia.
Case report
A 60-year-old man, who had intentionally ingested 450 mL of Roundup ® , a GlySH was brought to our emergency department by ambulance. The Roundup ® is formulated as a concentrate containing water, 41% glyphosate (as isopropylamine salt) and a surfactant of 15% polyoxyethyleneamine (POEA). He presented with a drowsy mental state with a Glasgow Coma score 10 (E2, V4, M4), tachypnoea, defaecation and u r i n a t i o n . H e w a s i n t u b a t e d a n d g a s t r i c decontamination was performed. His vital signs were blood pressure 90/60 mmHg, temperature 36.7 o C, respiratory rate 26 breaths/minute and heart rate 134 beats/minute. On auscultation, crackles were heard during inspiration and expiration. The results of arterial blood gas analysis were pH 6.960, PaCO 2 3.3 kPa, PaO 2 17.6 kPa and bicarbonate 5.8 mmol/L. Serum electrolyte concentrations were as follows: sodium 142 mmol/L; potassium 8.8 mmol/L and chloride 108 mmol/L. Other laboratory tests revealed leucocytosis (white blood cell 26,700/L), mild renal dysfunction (urea 11.7 mmol/L, creatinine 123.7 mol/L) and hyperglycaemia (13 mmol/L). Electrocardiogram (ECG) displayed sinus tachycardia with QRS widening and QTc prolongation (565 msec). the respiratory control ratios of mitochondria are supposed to be responsible. 8 Potentially fatal cases require early aggressive supportive and intensive care. Therefore, several studies have aimed to identify the risk factors and prognostic factors in GlySH poisoning. [2] [3] [4] 9 Regarding demographic characteristics, older age, larger ingested amount of GlySH, and delayed presentation could be associated with serious poisoning. 4, 9 Our case was potentially fatal in that he was 60 years old and had ingested a large volume of GlySH. The clinical signs of prognostic value were reported to be tachycardia, metabolic acidosis, hyperkalaemia, pulmonary oedema, and intractable shock. [2] [3] [4] Intractable shock was known to be a major cause of death after ingestion of GlySH. 2, 3 Severely intoxicated patients showed progressive intractable hypotension with metabolic acidosis or respiratory distress.
3,5,9,10
Those severely intoxicated patients should require early invasive monitoring, as well as ventilatory and haemodynamic support.
Although there has been no specific treatment, two adjunct treatments including the use of lipid emulsion and haemodialysis has been recommended for intractable hypotension after ingestion of GlySH. 5, 6 Han et al reported that intravenous lipid emulsion has the potential to reduce the toxicity of GlySH by lowering the free POEA concentration. 6 Two case reports had described the use of haemodialysis for GlySH poisoning. 5, 10 Stella and Ryan reported two cases that were fatal despite the use of haemodialysis. 10 On the other hand, Moon et al repor ted two s u c c e s s f u l l y r e s u s c i t a t e d c a s e s t r e a t e d w i t h haemodialysis. 5 They conducted haemodialysis for hyperkalaemia and metabolic acidosis. In the present case, the patient showed metabolic acidosis with hyperkalaemia, and respiratory distress, and he finally experienced cardiac arrest. Renal replacement therapy was given for the hyperkalaemia and severe metabolic acidosis. Haemodialysis has not been routinely recommended for GlySH poisoning. It was generally not recommended to remove the surfactant, due to its large molecular size. However, haemodialysis has been reported to be effective for hypotension with metabolic acidosis and hyperkalaemia. 5 We used CVVHDF i n s t e a d o f h a e m o d ia l y s i s b e c a u s e p r o v i d i n g haemodialysis is challenging in haemodynamically unstable patients. After using CVVHDF the metabolic acidosis resolved, and the patient's vital signs were stabilised.
Conclusion
In conclusion, all GlySH poisoned patients should receive close monitoring and supportive care. Severely poisoned patients require early invasive monitoring and haemodynamic support. Fur thermore, adjunct treatments including the use of intravenous lipid emulsion and renal replacement therapy should be considered for critical patients. Renal replacement therapy can be helpful in cases of intractable h y p o t e n s i o n w i t h m e t a b o l i c a c i d o s i s a n d hyperkalaemia. In addition, CVVHDF is safer than haemodialysis in haemodynamically unstable patients, and it may be efficient in removing the surfactant.
